Premium
Selenopeptide Analogs of EETI‐II Retain Potent Trypsin Inhibitory Activities
Author(s) -
Walewska Aleksandra,
Jaśkiewicz Anna,
Bulaj Grzegorz,
Rolka Krzysztof
Publication year - 2011
Publication title -
chemical biology and drug design
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 77
eISSN - 1747-0285
pISSN - 1747-0277
DOI - 10.1111/j.1747-0285.2010.01046.x
Subject(s) - trypsin , cysteine , chemistry , selenocysteine , peptide , stereochemistry , diphenyl diselenide , biochemistry , disulfide bond , residue (chemistry) , cyclic peptide , salt bridge , diselenide , enzyme , selenium , organic chemistry , mutant , gene
Three‐disulfide‐bridged Ecballium elaterium trypsin inhibitor II (EETI‐II) is a 28‐residue peptide that belongs to the squash family of canonical trypsin inhibitors. Herein, we report synthesis and biological activity of three EETI‐II analogs. In each of analog, a pair of cysteine residues forming a native disulfide bridge was individually replaced by a pair of selenocysteine residues. All selenopeptide analogs were chemically synthesized using the Fmoc protocol and subsequently folded in the presence of oxidized and reduced glutathione. The analogs containing a diselenide bridge displayed association constants with trypsin that ranged from 2.6 × 10 9 to 5.1 × 10 9 [M −1 ]. Our results suggest that the selenopeptide analogs retained low nanomolar inhibitory potencies, and only the diselenide bridge adjacent to the inhibitory binding loop weakened the interactions with trypsin by approximately fivefold. We discuss these findings in the context of a broader use of selenopeptide analogs as proxies to study cysteine‐rich peptides.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom